These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

807 related articles for article (PubMed ID: 34323179)

  • 1. Clinical Effects of Dual Antiplatelet Therapy or Aspirin Monotherapy after Acute Minor Ischemic Stroke or Transient Ischemic Attack, a Meta-Analysis.
    Condello F; Liccardo G; Ferrante G
    Curr Pharm Des; 2021; 27(40):4140-4146. PubMed ID: 34323179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clopidogrel and aspirin after ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis of randomized clinical trials.
    Kheiri B; Osman M; Abdalla A; Haykal T; Swaid B; Ahmed S; Chahine A; Hassan M; Bachuwa G; Al Qasmi M; Bhatt DL
    J Thromb Thrombolysis; 2019 Feb; 47(2):233-247. PubMed ID: 30511260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2Y12 Inhibitors Plus Aspirin Versus Aspirin Alone in Patients With Minor Stroke or High-Risk Transient Ischemic Attack.
    Li ZX; Xiong Y; Gu HQ; Fisher M; Xian Y; Johnston SC; Wang YJ
    Stroke; 2021 Jul; 52(7):2250-2257. PubMed ID: 34039032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ticagrelor plus aspirin in patients with minor ischemic stroke and transient ischemic attack: a network meta-analysis.
    Li M; Yang Q; Shi J; Zhang X; Lin H; Ge F
    BMC Neurol; 2023 Aug; 23(1):303. PubMed ID: 37580668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ticagrelor versus clopidogrel in dual antiplatelet therapy after minor stroke or transient ischemic attack: an updated network meta-analysis.
    Marinheiro G; Araújo B; Monteiro GA; Leite M; Mutarelli A; Almeida AM; Cavalcante-Neto JF; Rivera A; Pinheiro AC; Telles JPM
    J Neurol; 2024 Jun; 271(6):3030-3038. PubMed ID: 38580815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of aspirin plus clopidogrel versus aspirin alone in ischemic stroke or high-risk transient ischemic attack: A meta-analysis of randomized controlled trials.
    Ahmed M; Ahsan A; Fatima L; Basit J; Nashwan AJ; Ali S; Hamza M; Karalis I; Ahmed R; Alareed A; Ijioma NN; Alraies MC
    Vasc Med; 2024 Oct; 29(5):517-525. PubMed ID: 39164077
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of Dual Antiplatelet Therapies for Minor, Nondisabling, Acute Ischemic Stroke: A Bayesian Network Meta-Analysis.
    Lim A; Ma H; Ly J; Singhal S; Pan Y; Wang Y; Johnston SC; Phan TG
    JAMA Netw Open; 2024 May; 7(5):e2411735. PubMed ID: 38753327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clopidogrel with indobufen or aspirin in minor ischemic stroke or high-risk transient ischemic attack: a randomized controlled clinical study.
    Liu X; Lv X; Peng Y; Wang J; Lei J; Tang C; Luo S; Mai W; Cai Y; Fan Q; Liu C; Zhang L
    BMC Neurol; 2024 Mar; 24(1):81. PubMed ID: 38429754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Ticagrelor vs Clopidogrel in Addition to Aspirin in Patients With Minor Ischemic Stroke and Transient Ischemic Attack: A Network Meta-analysis.
    Lun R; Dhaliwal S; Zitikyte G; Roy DC; Hutton B; Dowlatshahi D
    JAMA Neurol; 2022 Feb; 79(2):141-148. PubMed ID: 34870698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of dual antiplatelet therapy in the elderly for stroke prevention: a systematic review and meta-analysis.
    Ding L; Peng B
    Eur J Neurol; 2018 Oct; 25(10):1276-1284. PubMed ID: 29855121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual Antiplatelet Therapy Versus Aspirin in Patients With Stroke or Transient Ischemic Attack: Meta-Analysis of Randomized Controlled Trials.
    Bhatia K; Jain V; Aggarwal D; Vaduganathan M; Arora S; Hussain Z; Uberoi G; Tafur A; Zhang C; Ricciardi M; Qamar A
    Stroke; 2021 Jun; 52(6):e217-e223. PubMed ID: 33902301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of dual versus mono antiplatelet therapy in patients with stroke or transient ischemic attack: An updated meta-analysis of 18 randomized controlled trials.
    Fu-Sang W; Xiao-Han Z; Yang Z; Ting-Ting C; Chao S; Jing-Yi L; Jian-Jun Z
    Pharmazie; 2020 Oct; 75(10):516-523. PubMed ID: 33305729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-Analysis of Usefulness of Antiplatelet Therapy in Ischemic Stroke or Transient Ischemic Attack.
    Medranda GA; Zhang C; Doros G; Yerasi C; Case BC; Weintraub WS; Waksman R
    Am J Cardiol; 2021 Aug; 153():129-134. PubMed ID: 34226040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin plus clopidogrel
    Ye MB; Chen YL; Wang Q; An J; Ye F; Jing P
    Scand Cardiovasc J; 2019 Aug; 53(4):169-175. PubMed ID: 31112048
    [No Abstract]   [Full Text] [Related]  

  • 15. P2Y12 inhibitors plus aspirin for acute treatment and secondary prevention in minor stroke and high-risk transient ischemic attack: A systematic review and meta-analysis.
    Pomero F; Galli E; Bellesini M; Maroni L; Squizzato A
    Eur J Intern Med; 2022 Jun; 100():46-55. PubMed ID: 35331593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P2Y12 receptor inhibitor plus aspirin versus aspirin treated within 24 hours of acute noncardioembolic ischemic stroke or TIA: Meta-analysis.
    Huang WY; Ovbiagele B; Lee M
    J Formos Med Assoc; 2022 Jun; 121(6):1053-1061. PubMed ID: 34426033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Meta-analysis on the efficacy and adverse events of aspirin plus clopidogrel versus aspirin-monotherapy in patients with ischemic stroke or transient ischemic attack].
    Yang C; Qian J; Tang X; Gao P; Hu Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Dec; 36(12):1430-5. PubMed ID: 26850406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time Course for Benefit and Risk With Ticagrelor and Aspirin in Individuals With Acute Ischemic Stroke or Transient Ischemic Attack Who Carry CYP2C19 Loss-of-Function Alleles: A Secondary Analysis of the CHANCE-2 Randomized Clinical Trial.
    Pan Y; Meng X; Jin A; Johnston SC; Li H; Bath PM; Xie X; Jing J; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Yang H; Cheng J; Wang Z; Wang Y
    JAMA Neurol; 2022 Aug; 79(8):739-745. PubMed ID: 35727586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Using Dual Versus Monotherapy Antiplatelet Agents in Secondary Stroke Prevention: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.
    Trifan G; Gorelick PB; Testai FD
    Circulation; 2021 Jun; 143(25):2441-2453. PubMed ID: 33926204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials.
    Pan Y; Elm JJ; Li H; Easton JD; Wang Y; Farrant M; Meng X; Kim AS; Zhao X; Meurer WJ; Liu L; Dietrich D; Wang Y; Johnston SC
    JAMA Neurol; 2019 Dec; 76(12):1466-1473. PubMed ID: 31424481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.